Generex Biotechnology Corporation (NASDAQ: GNBT), a leader in the area of buccal drug delivery, announced today that on July 1, 2006 Gerald Bernstein, M.D., the Company’s Vice-President for Medical Affairs, made a podium presentation in respect of Generex Oral-lyn™, the Company’s proprietary oral insulin spray product, at the 45th Annual Meeting of the European Society for Paediatric Endocrinology (www.espe2006.org) in Rotterdam, The Netherlands.
